Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering ...

Within each cell, there is a constant struggle between life-sustaining molecules and molecules that could hasten its demise.

Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...

How do stem cells know what to become? Nearly three decades after scientists isolated the first human embryonic stem cells, researchers are still working hard to understand precisely how a single, ...

Novartis will acquire Avidity Biosciences for $12 billion at $72 per share, gaining its RNA-targeting platform and neuroscience pipeline as Avidity spins off its precision cardiology programs into a ...

ProQR ( ($PRQR) ) has issued an announcement. On November 3, 2025, ProQR Therapeutics hosted a virtual analyst and investor event to discuss its ...

BMY's growth-driving portfolio increased 17% year-over-year, prompting an upward revision in 2025 revenue guidance and ...

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers have found a way to force tumors to trigger their own destruction.

Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...

For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...

A new study identifies biliverdin reductase A (BVRA) as a crucial enzyme defending neurons from oxidative stress, acting ...

The 54th International Symposium on High Performance Liquid Phase Separations and Related Techniques (HPLC 2025), was held from June 15–19, 2025, in Bruges, Belgium. This “Column Watch” installment ...